2021
DOI: 10.1016/j.msard.2020.102720
|View full text |Cite
|
Sign up to set email alerts
|

Factors influencing patients’ willingness-to-pay for disease-modifying therapies for multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…The survey also revealed that 8.1% of 3437 patients taking DMTs faced challenges to DMT use, including insurance denial in the first instance (3.3%) and when switching DMTs (2.3%) [ 65 ]. A patient’s willingness to pay for DMTs can be influenced by patient-related factors, such as demographics, health status, comorbidities, and MS experience, as well as drug-related factors (DMT effectiveness, safety, mode of administration, out-of-pocket expenses) [ 66 , 67 ]. A scoping review of 23 primarily US and European studies highlighted affordability of services could be a barrier to patients with MS, but having a dedicated HCP could ease the complexities of navigating the healthcare system for patients and identify possible funding sources [ 68 ].…”
Section: Overcoming Barriers To Sdmmentioning
confidence: 99%
“…The survey also revealed that 8.1% of 3437 patients taking DMTs faced challenges to DMT use, including insurance denial in the first instance (3.3%) and when switching DMTs (2.3%) [ 65 ]. A patient’s willingness to pay for DMTs can be influenced by patient-related factors, such as demographics, health status, comorbidities, and MS experience, as well as drug-related factors (DMT effectiveness, safety, mode of administration, out-of-pocket expenses) [ 66 , 67 ]. A scoping review of 23 primarily US and European studies highlighted affordability of services could be a barrier to patients with MS, but having a dedicated HCP could ease the complexities of navigating the healthcare system for patients and identify possible funding sources [ 68 ].…”
Section: Overcoming Barriers To Sdmmentioning
confidence: 99%
“…Previous studies focus on the willingness to pay for social health insurance or community-based health insurance [ 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ], factors influencing the willingness to pay for health insurance in general [ 36 , 37 , 38 , 39 , 40 ], and factors that affect the deficits in financing faced by BPJS-Kes as the agency that finances the NHI in Indonesia [ 10 , 11 , 41 , 42 ]. This study aimed to assess the factors that affect the willingness to pay for cost-sharing under the NHI scheme among patients with catastrophic illnesses in Yogyakarta, Indonesia.…”
Section: Introductionmentioning
confidence: 99%